Renee Leck | Director, Investor Relations |
Mark Rothera | President, Chief Executive Officer |
Bobby Gaspar | Chief Scientific Officer |
Frank Thomas | Chief Financial Officer and Chief Business Officer |
Anupam Rama | JPMorgan |
Ritu Baral | Cowen |
David Nierengarten | Wedbush Securities |
Graig Suvannavejh | Goldman Sachs |
Good day, ladies and gentlemen, and welcome to the Orchard Therapeutics First Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions] And as a reminder, today’s conference call is being recorded. I’d now like to turn the conference over to Renee Leck, Director of Investor Relations.